While there are no reliable national estimates of the prevalence of drug diversion activity by U.S. healthcare personnel, diversion occurs in facilities across the US every day. Access to narcotics by clinical personnel represents an underappreciated occupational hazard and patient safety risk. Harm to patients from healthcare personnel who divert opioids may take many forms, including care delivered by an impaired provider, untreated pain, and infection risks stemming from tampering with injectable drugs. This webinar will outline fundamental components of adiversion prevention, detection, and response program. An overview of the scope of the problem will be provided, and safety and quality implications will be demonstrated by actual case studies. Regulatory, statutory and quality standards relating to controlled substance security and diversion will be detailed.
Protect Patients from Drug Diversion with a Prevention Program
1. Overview
Drug Diversion by Healthcare Personnel -Prevention Program
to Protect Your Patients, Employees, and Organization.
Date: Tuesday, July 07th, 2015 || Time: 01:00 PM EDT | 10:00 AM PST
Duration: 60 Minutes || Course Level: Beginner
'Live' Webinar by Kimberly New
While there are no reliable national estimates of the prevalence of drug diversion activity
by U.S. healthcare personnel, diversion occurs in facilities across the US every day.
Access to narcotics by clinical personnel represents an underappreciated occupational
hazard and patient safety risk. Harm to patients from healthcare personnel who divert
opioids may take many forms, including care delivered by an impaired provider,
untreated pain, and infection risks stemming from tampering with injectable drugs. This
webinar will outline fundamental components of adiversion prevention, detection, and
response program. An overview of the scope of the problem will be provided, and safety
and quality implications will be demonstrated by actual case studies. Regulatory,
statutory and quality standards relating to controlled substance security and diversion will
be detailed.
Why should you attend?
Diversion by healthcare personnel presents an underappreciated risk to patients and
healthcare personnel. Diversion within healthcare facilities is a multi-victim crime that
causes a significant risk of civil and regulatory liability and negative publicity to healthcare
facilities. Facilities vary greatly in their approach to diversion by clinicians and other staff,
but a formal program is essential to properly prevent, detect, and respond to diversion.
Areas covered in the webinar
This webinar will include a discussion of the scope of the problem of diversion within
healthcare facilities by healthcare personnel. Healthcare regulatory requirements for
controlled substance security and tracking will be detailed. The essential elements of a
robust program will be provided.
Learning objective
• By attending this presentation, the learner will be able to describe the impact of
diversion by healthcare personnel on patient safety goals and quality of care
Register Now
2. • By attending this presentation, the learner will be able to state the essential
components of a diversion prevention, detection and response program
• By attending this presentation, the learner will be able to implement a diversion
program that will help protect patients, staff and the community from the risks of diversion
by healthcare personnel
Who will benefit
• HospitalManagersandExecutives
• Risk Managers
• Pharmacists/Physicians
• Compliance Personnel
• Law Enforcement Personnel
• Regulatory Investigators
• Security Personnel
• Researchers
Speaker profile
Kim is a specialist in controlled substance security and DEA regulatory
compliance and is a consultant to healthcare facilities across the
country. She works with facilities to set up and expand their drug
diversion programs with the goal of improving patient safety. She is a
nurse and an attorney. Kim is also a frequent author and national
speaker on the subject of health facility diversion. She has been featured in USA Today
and the Wall Street Journal, and has served as a guest author for the CDC Safe
Healthcare and DHHS aids.gov blogs.